Belinda S Cowling Selected Research

Muscular Diseases (Myopathy)

1/2022	BIN1 modulation in vivo rescues dynamin-related myopathy.
6/2019	Allele-Specific CRISPR/Cas9 Correction of a Heterozygous DNM2 Mutation Rescues Centronuclear Myopathy Cell Phenotypes.
1/2018	Single Intramuscular Injection of AAV-shRNA Reduces DNM2 and Prevents Myotubular Myopathy in Mice.
10/2017	Expression of the neuropathy-associated MTMR2 gene rescues MTM1-associated myopathy.
1/2017	Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice.
6/2013	Altered splicing of the BIN1 muscle-specific exon in humans and dogs with highly progressive centronuclear myopathy.
4/2011	Four and a half LIM protein 1 gene mutations cause four distinct human myopathies: a comprehensive review of the clinical, histological and pathological features.
9/2009	SLIMMER (FHL1B/KyoT3) interacts with the proapoptotic protein Siva-1 (CD27BP) and delays skeletal myoblast apoptosis.
12/2008	Identification of FHL1 as a regulator of skeletal muscle mass: implications for human myopathy.
3/2008	Proteomic identification of FHL1 as the protein mutated in human reducing body myopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Belinda S Cowling Research Topics

Disease

22	Congenital Structural Myopathies (Centronuclear Myopathy) 01/2022 - 05/2011
10	Muscular Diseases (Myopathy) 01/2022 - 03/2008
4	Disease Progression 01/2022 - 01/2012
4	Neuromuscular Diseases (Neuromuscular Disease) 01/2020 - 01/2012
2	Muscle Weakness 01/2022 - 05/2011
2	Neoplasms (Cancer) 01/2020 - 08/2013
1	Rare Diseases (Rare Disease) 01/2021
1	Brain Diseases (Brain Disorder) 01/2020
1	Inborn Genetic Diseases (Disease, Hereditary) 06/2019
1	Paralysis (Palsy) 11/2018
1	Breast Neoplasms (Breast Cancer) 11/2018
1	Atrophy 10/2017
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2017
1	Muscle Hypotonia (Hypotonia) 03/2014
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 02/2014
1	Hypertrophy 02/2014
1	Prostatic Neoplasms (Prostate Cancer) 08/2013
1	Myotonic Dystrophy (Dystrophia Myotonica) 06/2013
1	Rigid spine syndrome 09/2009
1	Scapuloperoneal myopathy 09/2009
1	Muscular Atrophy (Muscle Atrophy) 09/2009

Drug/Important Bio-Agent (IBA)

13	Dynamin IIIBA 01/2022 - 05/2011
11	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2008
9	myotubularinIBA 10/2021 - 01/2012
8	amphiphysinIBA 01/2022 - 01/2012
4	Antisense OligonucleotidesIBA 01/2022 - 01/2017
4	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2019 - 01/2012
3	Dynamins (Dynamin)IBA 01/2022 - 01/2012
3	Protein Isoforms (Isoforms)IBA 11/2020 - 09/2009
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2018 - 01/2012
2	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 10/2021 - 01/2018
2	Phosphoinositide PhosphatasesIBA 10/2021 - 04/2013
2	Tamoxifen FDA LinkGeneric 10/2021 - 11/2018
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2020
2	GTP Phosphohydrolases (GTPases)IBA 01/2020 - 01/2018
2	phosphatidylinositol 3-phosphateIBA 04/2013 - 01/2012
1	CalciumIBA 10/2021
1	MyostatinIBA 06/2020
1	Pharmaceutical PreparationsIBA 11/2018
1	Small Interfering RNA (siRNA)IBA 01/2018
1	UtrophinIBA 02/2014
1	AndrogensIBA 08/2013
1	CalpainIBA 08/2013
1	Transcription Factors (Transcription Factor)IBA 08/2013
1	FilaminsIBA 08/2013
1	Androgen Receptors (Androgen Receptor)IBA 08/2013
1	LigandsIBA 08/2013
1	phosphatidylinositol 5-phosphateIBA 01/2012

Therapy/Procedure

7	Therapeutics 10/2020 - 08/2013
1	Intramuscular Injections 01/2018